Patent №
US 8,079,367
Granted
—
Owner
—
Lab
—
AI components
2
vision · hardware
Assignment
None on record
Dataset
AIPD
2023_r1 edition
Application
12172127
Devices, systems, and methods for developing prescriptions for and/or treating presbyopia may use a combination of an alteration to the refractive tissues of the eye with changes in the response of the visual system. The visual system response may include using residual accommodation in a manner similar to that employed by latent hyperopes, a trained response of the pupil, trained psychophysics, or the like. Associated refractive prescriptions may be tailored to take advantage of the subsequent visual system response so as to mitigate presbyopia.